Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 22% ± 4% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 4% | |
gamma-delta T cell | 4 studies | 22% ± 5% | |
natural killer cell | 4 studies | 18% ± 1% | |
CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 4% | |
lymphocyte | 3 studies | 17% ± 2% | |
hepatocyte | 3 studies | 39% ± 19% |
Insufficient scRNA-seq data for expression of PSD4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 6853.86 | 653 / 653 | 100% | 26.54 | 605 / 605 |
pancreas | 100% | 3602.78 | 327 / 328 | 99% | 21.84 | 177 / 178 |
lung | 99% | 3275.54 | 574 / 578 | 99% | 17.65 | 1142 / 1155 |
liver | 100% | 7077.68 | 226 / 226 | 96% | 14.36 | 391 / 406 |
prostate | 91% | 5712.27 | 224 / 245 | 100% | 35.84 | 502 / 502 |
kidney | 100% | 2456.30 | 89 / 89 | 90% | 10.20 | 811 / 901 |
stomach | 78% | 4308.95 | 281 / 359 | 98% | 18.89 | 281 / 286 |
breast | 65% | 2582.22 | 298 / 459 | 99% | 25.04 | 1109 / 1118 |
intestine | 54% | 3419.08 | 521 / 966 | 100% | 19.35 | 526 / 527 |
bladder | 52% | 1687.62 | 11 / 21 | 97% | 16.08 | 488 / 504 |
adrenal gland | 100% | 6825.97 | 258 / 258 | 49% | 5.62 | 113 / 230 |
esophagus | 42% | 1925.89 | 603 / 1445 | 100% | 21.83 | 183 / 183 |
skin | 73% | 3542.55 | 1317 / 1809 | 46% | 5.02 | 216 / 472 |
uterus | 14% | 202.84 | 24 / 170 | 90% | 14.79 | 414 / 459 |
ovary | 4% | 47.50 | 8 / 180 | 99% | 15.82 | 425 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.90 | 29 / 29 |
spleen | 100% | 11707.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.84 | 1 / 1 |
peripheral blood | 100% | 13589.00 | 927 / 929 | 0% | 0 | 0 / 0 |
brain | 30% | 312.76 | 780 / 2642 | 29% | 1.95 | 202 / 705 |
adipose | 42% | 560.13 | 510 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 180.60 | 159 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.63 | 9 / 80 |
heart | 3% | 35.35 | 27 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.22 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032012 | Biological process | regulation of ARF protein signal transduction |
GO_0032587 | Cellular component | ruffle membrane |
GO_0032154 | Cellular component | cleavage furrow |
GO_0016020 | Cellular component | membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | PSD4 |
Protein name | Pleckstrin and Sec7 domain containing 4 PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein) |
Synonyms | EFA6B TIC |
Description | FUNCTION: Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 4,5-bisphosphate. . |
Accessions | ENST00000245796.11 [Q8NDX1-1] ENST00000409656.5 B8ZZZ5 Q8NDX1 H7BZ06 ENST00000409378.1 ENST00000441564.7 [Q8NDX1-2] |